PR release

Contract extension follows benefits realized from Dario's cardiometabolic program and strong employee demand for perimenopause support

In this free webinar, explore the potential of extracellular vesicles and particles (EVPs) as liquid biopsy analytes for early cancer detection. Learn how EVPs differ from circulating tumor DNA and how detecting multiple cancer-associated biomarkers on the same particle can help distinguish tumor-associated signals from background signals. Drawing on findings from ovarian and lung cancer studies, the featured speaker will discuss the opportunities, current evidence, and remaining challenges in translating EVP-based approaches into clinical diagnostics.

Vantive plans to expand its HomeAdvantage offering with the next-generation Avira automated peritoneal dialysis cycler, which is progressing through health authority processes in select countries and is not yet available for sale.

Phase I contract supports the development of TRAUMAGEL for military personnel operating without immediate access to medical support

Malaysia and Indonesia, home to more than 310 million people with a fast-growing need for mental health care, form the initial focus of an initiative combining neuroscience devices, professional education and AI-supported mental healthcare

UTRECHT, Netherlands , Oct. 26, 2026 /PRNewswire/ -- Medline celebrates its 10th year of partnership with Worldwide Responsible Accredited Production (WRAP), marking a decade of continued work on responsible business practices, ethical manufacturing and supply chain integrity.

BINYAMINA, Israel and CARY, N.C. , Oct. 26, 2026 /PRNewswire/ -- OncoHost, a technology company transforming the approach to predictive precision diagnostics for improved patient outcomes, today announced new research that was presented at the European Society for Medical Oncology (ESMO) 2026 Congress, taking place October 23–27 in Madrid, Spain.

CHENGDU, China , Oct. 24, 2026 /PRNewswire/ -- At the 19th EU-China Business Meeting, co-hosted by the China Chamber of International Commerce (CCOIC) and the European Union Chamber of Commerce in China (EUCCC) in Chengdu, LivingPHOENIX Regenerative Technology Development (Chengdu) Co., Ltd. (hereinafter referred to as "LivingPHOENIX"), a tenant enterprise of Tianfu International Bio City, achieved a significant milestone. Dr. Qin Xingjiong, the company's founder, led his industrialization team to attend the event and witnessed the Global Launch Preview Ceremony of the company's core product: POGMENT® Triple-Helix Biomimetic Collagen-Based Extracellular Matrix (ECM) Medical Devices . This launch not only marks China's technological leap from "catching up" to "leading" in the field of high-end regenerative medicine materials but also demonstrates the strength of intelligent manufacturing in China to the international market.

Research Will Use Lunit's AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment Biology

- Silicone foam dressings featuring MegaSorb™ technology were included in attendee gift bags to support at-home management of exuding wounds

Company to participate in TCT for the first time as the ALARA+ consensus statement elevates industry focus on occupational radiation exposure and injury in fluoroscopy-guided medicine

DELRAY BEACH, Fla. , Oct. 23, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Next-generation Sequencing Services Market is projected to reach USD 9.37 billion by 2031 from USD 3.96 billion in 2026, at a CAGR of 18.8% during the forecast period.

CHICAGO , Oct. 23, 2026 /PRNewswire/ -- Ziegler, a specialty investment bank, is pleased to announce it served as the exclusive financial advisor to Impression Imaging on its acquisition by Capitol Imaging Services, a leading operator of imaging centers across the United States. This partnership adds four state of the art centers, and more than 50 team members to Capitol Imaging's national network, further strengthening the organization's presence in the Florida market.

Beta-CORRECT study shows a 10.6-fold higher risk of recurrence, reinforcing the prognostic value of molecular residual disease (MRD) testing 1

Secures its 13th FDA 510(k) clearance, expanding its U.S. portfolio from lung nodule detection and coronary artery calcium (CAC) analysis to quantitative aortic assessment

A study of more than 14,000 adults explores how sleep patterns are associated with visceral fat and brain volume

Labcorp intends to be the first commercial laboratory to offer FDA-approved HPV testing with the BD Onclarity™ HPV Assay across clinician-collected and self-collected screening options in clinic, patient service center, and at-home settings

Korean-Swedish consortium brings together Yonsei University, Dankook University, Uppsala University and Xantage AB

Founded by health tech entrepreneur Richard Chambers with Dr Luke Pratsides

The Department marks its anniversary by spotlighting innovations in multidisciplinary and minimally invasive care, alongside a flagship international congress that fosters global collaboration in ophthalmology